Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Great interview. Things are definitely moving forward

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Mar 04, 2024 8:06pm

86 Views

Post# 35914714

RE:RE:RE:RE:Great interview. Things are definitely moving forward

If they manage to do this it should really upend the contrast space

"Introducing an advanced suite of new barium contrast media products, with the goal to displace current products in the market.

Expanding Voyageur’s Iodine contrast media product pipeline, including potential development of fullerene iodine products"

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023